Literature DB >> 27801453

Compound K derived from ginseng: neuroprotection and cognitive improvement.

Jisun Oh1, Jong-Sang Kim1.   

Abstract

The evidence for the neuroprotective and cognitive effects of compound K, a metabolite biotransformed from ginsenosides Rb1, Rb2, and Rc, is reviewed here. Compound K is more bioavailable than other ginsenosides and therefore has greater potential to exert bioactive functions in the body. Although the capability of compound K to cross the blood-brain barrier is not clear, it has been reported to have neuroprotective and cognition enhancing effects and decrease inflammatory biomarkers in animal models of Alzheimer's disease and cerebral ischemia. The plethora of potential health benefits of compound K warrants further research to evaluate its biochemical mechanisms and its ability to protect healthy populations from neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27801453     DOI: 10.1039/c6fo01077f

Source DB:  PubMed          Journal:  Food Funct        ISSN: 2042-6496            Impact factor:   5.396


  24 in total

1.  Ginsenoside compound K reduces the progression of Huntington's disease via the inhibition of oxidative stress and overactivation of the ATM/AMPK pathway.

Authors:  Kuo-Feng Hua; A-Ching Chao; Ting-Yu Lin; Wan-Tze Chen; Yu-Chieh Lee; Wan-Han Hsu; Sheau-Long Lee; Hsin-Min Wang; Ding-I Yang; Tz-Chuen Ju
Journal:  J Ginseng Res       Date:  2021-11-11       Impact factor: 5.735

2.  The ginsenoside metabolite compound K inhibits growth, migration and stemness of glioblastoma cells.

Authors:  Sanghun Lee; Min Cheol Kwon; Jun-Pil Jang; Jae Kyung Sohng; Hye Jin Jung
Journal:  Int J Oncol       Date:  2017-06-23       Impact factor: 5.650

3.  Food and Sex-Related Impacts on the Pharmacokinetics of a Single-Dose of Ginsenoside Compound K in Healthy Subjects.

Authors:  Lulu Chen; Luping Zhou; Yaqin Wang; Guoping Yang; Jie Huang; Zhirong Tan; Yicheng Wang; Gan Zhou; Jianwei Liao; Dongsheng Ouyang
Journal:  Front Pharmacol       Date:  2017-09-13       Impact factor: 5.810

Review 4.  Ginsenoside Compound K: Insights into Recent Studies on Pharmacokinetics and Health-Promoting Activities.

Authors:  Anshul Sharma; Hae-Jeung Lee
Journal:  Biomolecules       Date:  2020-07-10

Review 5.  Efficacy and Mechanism of Panax Ginseng in Experimental Stroke.

Authors:  Lei Liu; Gigi A Anderson; Tyler G Fernandez; Sylvain Doré
Journal:  Front Neurosci       Date:  2019-04-24       Impact factor: 4.677

Review 6.  Neuroprotective Potentials of Panax Ginseng Against Alzheimer's Disease: A Review of Preclinical and Clinical Evidences.

Authors:  Jing Li; Qingxia Huang; Jinjin Chen; Hongyu Qi; Jiaqi Liu; Zhaoqiang Chen; Daqing Zhao; Zeyu Wang; Xiangyan Li
Journal:  Front Pharmacol       Date:  2021-06-02       Impact factor: 5.810

7.  Single- and Multiple-Dose Trials to Determine the Pharmacokinetics, Safety, Tolerability, and Sex Effect of Oral Ginsenoside Compound K in Healthy Chinese Volunteers.

Authors:  Lulu Chen; Luping Zhou; Jie Huang; Yaqin Wang; Guoping Yang; Zhirong Tan; Yicheng Wang; Gan Zhou; Jianwei Liao; Dongsheng Ouyang
Journal:  Front Pharmacol       Date:  2018-01-11       Impact factor: 5.810

8.  Synergistic effect of maclurin on ginsenoside compound K induced inhibition of the transcriptional expression of matrix metalloproteinase-1 in HaCaT human keratinocyte cells.

Authors:  Sang Yeol Lee
Journal:  J Ginseng Res       Date:  2017-11-21       Impact factor: 6.060

9.  The skin protective effects of compound K, a metabolite of ginsenoside Rb1 from Panax ginseng.

Authors:  Eunji Kim; Donghyun Kim; Sulgi Yoo; Yo Han Hong; Sang Yun Han; Seonggu Jeong; Deok Jeong; Jong-Hoon Kim; Jae Youl Cho; Junseong Park
Journal:  J Ginseng Res       Date:  2017-03-25       Impact factor: 6.060

10.  The Effects of Ginsenoside Compound K Against Epilepsy by Enhancing the γ-Aminobutyric Acid Signaling Pathway.

Authors:  Xiangchang Zeng; Kai Hu; Lulu Chen; Luping Zhou; Wei Luo; Chaopeng Li; Wenjing Zong; Siyu Chen; Qing Gao; Guirong Zeng; Dejian Jiang; Xiaohui Li; Honghao Zhou; Dong-Sheng Ouyang
Journal:  Front Pharmacol       Date:  2018-09-11       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.